Navigation Links
22nd Annual International Congress on Endovascular Interventions Convenes in Scottsdale, Arizona
Date:2/9/2009

World Experts to Announce Late-Breaking Developments in Endovascular Treatments for Cardiovascular Diseases

PHOENIX, Feb. 9 /PRNewswire/ -- International Congress Foundation is pleased to present International Congress XXII on Endovascular Interventions, a global educational forum where leading cardiovascular specialists assemble to discuss the newest developments in endovascular therapies.

Hosted by Arizona Heart Institute and supported by Arizona Heart Foundation, International Congress XXII takes place February 8-12, 2009 at the Phoenician Resort in Scottsdale, Arizona. Throughout the week, the latest advances and breaking news on endovascular technologies and techniques are announced through a combination of peer-reviewed abstract presentations by an international faculty, spirited debates and panel discussions. Live-case demonstrations of complex interventions are also broadcast via high-definition satellite from Arizona Heart Hospital endovascular suites and cardiac catheterization laboratories and Arizona Heart Institute Translational Research Center.

"The emphasis on advanced endovascular techniques, many developed at Arizona Heart Institute, has been the hallmark of International Congress for 22 years," said Dr. Edward B. Diethrich, International Congress Chairman and Founder/Medical Director of Arizona Heart Institute and Arizona Heart Hospital. "This year is no exception, as the Power of Three--Arizona Heart Institute, Arizona Heart Hospital and Arizona Heart Foundation & Translational Research Center--continues to forge new frontiers in cardiovascular medicine in all areas of patient care, research and education," continued Diethrich. "Despite today's challenging economic climate, we are more dedicated than ever to delivering superior care to all patients, both locally and globally."

International Congress XXII on Endovascular Interventions is a significant source of breaking news on multiple topics related to cardiovascular surgery and minimally invasive intervention such as:

        Abdominal Aortic Aneurysm: New Devices, Tools, and Techniques
        Indications for Stand-Alone Thoracic Endografting, Open Surgery and
        Hybrid Techniques
        Carotid Artery Stenting: Unresolved Problems and Questions
        Controversies in the Treatment of Peripheral Vascular Diseases
        Endovenous Treatment Modalities
        New Directions in Cardiovascular Imaging
        Multidisciplinary Approaches to Managing Lower Extremity Pain
        Creative Endovascular Surgical and Wound Care Solutions for Limb
        Salvage
        Holistic Approaches which Complement Cardiovascular Medicine
        Cardiac Stem Cell Treatment of Heart Failure and Residual Myocardial
        Ischemia
        Cell Therapy for Peripheral Vascular Disease
        The Future of Regenerative Medicine and Biogenomics

Obtain the latest details on International Congress on Endovascular Interventions at www.endovascularcongress.org. For media inquiries, contact Maggie Cocco at (602)-707-3519, mcocco@azheart.com.


'/>"/>
SOURCE Arizona Heart Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
2. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
3. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
4. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
5. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
6. Annual flu shot cuts need for doctors visits, hospitalization among children
7. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
8. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
9. Chem Rx to Present at Bear Stearns 20th Annual Healthcare Conference
10. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
11. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... More than 20,000 pairs of ... Congo (DRC) thanks to an ambitious venture that conjoined the passions of an NBA ... support of the Liberty community. These shoes will save lives from the rampant infections ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the National ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... 2017 , ... Radabaugh & Associates, a family managed agency ... West Virginia, is embarking on a cooperative charity effort with the Chestnut Mountain ... Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men offering ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an ... is campaigning in support of Campagna Academy in a charity drive to provide for ... Boys’ Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... AccuGenomics, Inc., a diagnostic company based in ... the company has provided an AccuKit to the HIV ... Chapel Hill and to Qura Therapeutics for evaluation in ... HIV reservoir and viral expression in human CD4+ T ... Center is a joint initiative between the University of ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: